Peer Review History
| Original SubmissionJune 10, 2022 |
|---|
|
PONE-D-22-16741Correlation of the antibacterial activity of commercial manuka and Leptospermum honeys from Australia and New Zealand with methylglyoxal content and other physicochemical characteristicsPLOS ONE Dear Dr. Hammer, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by October 6, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Abdelwahab Omri, Pharm B, Ph.D, Laurentian University, Canada Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: No Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The present work is very interesting as it characterises 29 manuka/Leptospermum honeys and tries to associate to their content the potential antibiotical properties usually ascribed to them. The paper is well-structured and the English form is good. I have just a few comments to the authors for improving their manuscript. a) The patronymic of the scientific names of the plant species mentioned in the text should be reported. b) In the introduction or better in the discussion section, the authors should report the recent discoverey that honey also contain microRNA from gathered plants and bees and that also these coumpounds can also exert a potential biological role (antibiotical for instance?). This innovative aspect should be mentioned and commented with its own future perspectives. See and cite: BMC genomics, 2021, 22.1: 1-14; PLoS One, 2017, 12.2: e0172981; Food Chemistry: Molecular Sciences, 2021, 2: 100014. c) How did the authors select the bacterial species to be tested? d) In table 1, the unit of measure for the antibacterial activity value should be indicated e) In general, the captions of the tables should be more descriptive of the content of the relative table. f) asterisks indicating the significance of the data, compared to the control, should be reported in Fig 3 g) can be figure 1 and 2 made in color and not in scale of grey? Reviewer #2: This is an interesting paper about manuka honeys. In fact, it is a paper on a highly competitive field, however, presents some quite surprising findings. Therefore it is publishable. In order to beneficiary improve the paper some changes in its layout are acknowledged. They are as follows (in random order); 1./ Table 1 characterizes the studied honeys. since the differences in MGO content provided by producers are unormously high in some samples (the same considers this content determined by Authors and presented in Table 2) there would be desirable to provide melissopalynologal data, at least for honeys showing extreme values; 2./ multifloral honey should be more detaily characterized in Experimental (geographic origin, producer ect.) while for artificial one producer should be identified; 3./ In Table 5 MIC data should be rather given not % data. If Author prefer the latter the detailed meaning should be given - for example 9% means high antibacterial activity but doean not give the reader the idea how strong is it. Other small comments are as follows (in order of appearance): a./ line 75 - please provide proper citation; b./ Table 1 - is there really level of MGO content in MN02 sample was given as "0" by the producer? Or is it not given (on the other hand this honey seems as not being manuka also from data received by Authors; c./ line 108 - were not was; d./ line 130 - what Author mean by "aliquatos"; e./ line 205 -it is better to write that multifloral and artificial honeys serve as some kind of controls; f./ line 245 E. coli should be in italics; g./ line 249 -what Authors mean by statistical comparisons. In my opinion statistics was not performed at all; h./ line 266 - do Authors mean that generation of hydrogen peroxide was negligible or small in comparison with other honeys? i./ lines 403-403 - HMF level in regions of higher temperature is often quite high; m./ line 440: do Authors mean that osmotic activity is of lower meaning that MGO content and thus manuka honeys antimicrobial acrion comes from appropriate lebvel of MGO? n./ it would be beneficial id heat maps would be coloured. Reviewer #3: - Abstract need more revision to be attractive for the reader. - References should be updated. - statistical analysis must be done for all your manuscript results. - Figures are not clear you should be represented in higher resolution. Reviewer #4: This study reviews the characteristics of 30 honeys and their antimicrobial activity against 4 type strains of bacteria. It is a comprehensive analysis of many honey samples that convincingly demonstrates the variability between the many manuka and Leptospermum honeys on the market. Specific comments are as follows: -Despite testing four species of organism, only 1 strain of each was tested and four is far from a comprehensive range of bacterial pathogens, and is not that far different from testing one strain. Please tone down the language in lines 24, 485-486. Also in the Discussion, the authors should not overgeneralize their findings related to organism species, as only 1 strain of each of 4 species was tested. Please revise the language in lines 443-473. -Honeys were analysed within three months of acquisition (page 5). It would also be informative to include the duration of time that elapsed between the quantitation of physicochemical parameters and measurements of antimicrobial activity. -Please provide a clear rationale for testing synergy of MGO with honey, as MGO is already known to be the main antimicrobial component of manuka honey, and the relationship between its concentration and antimicrobial activity has already been established. Synergy (e.g., line 482) seems not to be the appropriate term to use. Lines 341-343 data should be presented perhaps as a supplemental Table. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Paweł Kafarski Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Correlation of the antibacterial activity of commercial manuka and Leptospermum honeys from Australia and New Zealand with methylglyoxal content and other physicochemical characteristics PONE-D-22-16741R1 Dear Dr. Katherine Ann Hammer, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Abdelwahab Omri, Pharm B, Ph.D, Laurentian University, Canada Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-22-16741R1 Correlation of the antibacterial activity of commercial manuka and Leptospermum honeys from Australia and New Zealand with methylglyoxal content and other physicochemical characteristics Dear Dr. Hammer: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Abdelwahab Omri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .